BAM Management
Latest statistics and disclosures from BAM Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ONTY, BPAX, Genvec, RXII. These five stock positions account for 100.00% of BAM Management's total stock portfolio.
- Added to shares of ONTY, BPAX, Genvec.
- Reduced shares in these stocks: RXII.
- As of Sept. 30, 2011, BAM Management has $12.95M in assets under management (AUM). Assets under management grew from a total value of $10.70M to $12.95M.
- Independent of market fluctuations, BAM Management was a net buyer by $5.21M worth of stocks in the most recent quarter.
BAM Management portfolio companies for quarter ending September 2011
| Ticker | Name | Portfolio Weight | Change | Share Count | Price | Last Trade |
|---|---|---|---|---|---|---|
| ONTY | Oncothyreon | 57.60 | +66.00% | 1247136 | 5.98 | 1.74 |
| BPAX | BioSante Pharmaceuticals | 38.60 | +89.00% | 2191800 | 2.28 | 1.25 |
| Genvec | 2.42 | +20.00% | 109024 | 2.87 | 0.00 | |
| RXII | RXi Pharmaceuticals Corporation | 1.38 | -51.00% | 177406 | 1.01 | 0.20 |
Past 13F-HR SEC Filings for BAM Management
- BAM Management 2011 Q2 - filed Aug. 15, 2011
- BAM Management 2011 Q1 - filed May 16, 2011
- BAM Management 2010 Q4 - filed Feb. 14, 2011